Predicting Motor Decline and Disability in Parkinson Disease: A Systematic Review | Dementia and Cognitive Impairment | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Navigation Landing]
Neurological Review
November 2002

Predicting Motor Decline and Disability in Parkinson Disease: A Systematic Review

Author Affiliations

From the Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University Health Network, University of Toronto (Drs Marras and Lang), the Kunin-Lunenfeld Applied Research Unit, Baycrest Center for Geriatric Care, University of Toronto (Dr Rochon), and the Institute for Clinical and Evaluative Sciences (Dr Rochon), Toronto, Ontario.



Arch Neurol. 2002;59(11):1724-1728. doi:10.1001/archneur.59.11.1724

Context  The clinical course of Parkinson disease (PD) varies from patient to patient. A number of studies investigating predictors of prognosis in patients with PD have been performed.

Objective  To summarize evidence on predicting the rate of motor decline and increasing disability in early PD.

Data Sources  English-language and French-language literature cited in the MEDLINE database (1966-2002).

Study Selection  Cohort and case-control studies investigating associations between clinical features and subsequent motor impairment or disability were selected.

Data Extraction  Study methods and results were abstracted by a single reviewer.

Data Synthesis  The results of 13 studies were summarized qualitatively. Study methods were highly variable, particularly regarding the choice of outcome measure. Baseline motor impairment and cognitive impairment are probable predictors of more rapid motor decline and disability. A lack of tremor at onset and older age both appear to be predictive of increasing disability, but conflicting results exist for their association with the rate of change of motor impairment. Family history of PD does not appear to be prognostically important. The prognostic value of many other factors studied is uncertain owing to conflicting or unconfirmed results.

Conclusions  Uncertainty remains about the prognostic importance of many baseline clinical features in PD. Greater baseline impairment, early cognitive disturbance, older age, and lack of tremor at onset appear to be adverse prognostic factors.